tiprankstipranks
Advertisement
Advertisement

CHRS Stock Latest News

Coherus, Zumutor collaborate for ZM008, Loqtorzi combination study
The FlyCoherus, Zumutor collaborate for ZM008, Loqtorzi combination study
13d ago
CHRS
Coherus Biosciences Announces 2026 Stockholder Meeting Results
PremiumCompany Announcements
Coherus Biosciences Announces 2026 Stockholder Meeting Results
1M ago
8K
CHRS
Coherus Biosciences Signals Momentum in Earnings Call
PremiumCompany Announcements
Coherus Biosciences Signals Momentum in Earnings Call
2M ago
CHRS
Coherus Biosciences Signals Confident Oncology Earnings Outlook
PremiumCompany Announcements
Coherus Biosciences Signals Confident Oncology Earnings Outlook
2M ago
CHRS
Analyst Reiterates Buy on Loqtorzi Momentum and Temporary Q1 Headwinds; $7 Price Target Maintained
PremiumRatings
Analyst Reiterates Buy on Loqtorzi Momentum and Temporary Q1 Headwinds; $7 Price Target Maintained
2M ago
CHRS
Coherus Oncology reports Q1 EPS (28c), consensus (26c)
PremiumThe FlyCoherus Oncology reports Q1 EPS (28c), consensus (26c)
2M ago
CHRS
Guggenheim starts Coherus with Buy on anti-tumor potential
Premium
The Fly
Guggenheim starts Coherus with Buy on anti-tumor potential
2M ago
CHRS
Coherus Oncology initiated with a Buy at Guggenheim
Premium
The Fly
Coherus Oncology initiated with a Buy at Guggenheim
2M ago
CHRS
CHRS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CHRS Earnings this Week: How Will it Perform?
2M ago
CHRS
Coherus BioSciences Charts Leaner Path After Earnings Call
PremiumCompany Announcements
Coherus BioSciences Charts Leaner Path After Earnings Call
3M ago
CHRS
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline
PremiumRatings
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline
4M ago
CHRS
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
PremiumRatings
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
4M ago
CHRS
Coherus Oncology reports Q4 EPS (34c), consensus (31c)
PremiumThe FlyCoherus Oncology reports Q4 EPS (34c), consensus (31c)
4M ago
CHRS
Options Volatility and Implied Earnings Moves Today, March 09, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 09, 2026
4M ago
DDD
HPE
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
CHRS
Coherus Biosciences Completes $47 Million Equity Offering
PremiumCompany Announcements
Coherus Biosciences Completes $47 Million Equity Offering
5M ago
8K
CHRS
Coherus Oncology 28.6M share Spot Secondary priced at $1.75
PremiumThe Fly
Coherus Oncology 28.6M share Spot Secondary priced at $1.75
5M ago
CHRS
Coherus Oncology announces common stock offering, no amount given
PremiumThe Fly
Coherus Oncology announces common stock offering, no amount given
5M ago
CHRS
Coherus Signs Clinical Supply Deal With Janssen Oncology
PremiumCompany Announcements
Coherus Signs Clinical Supply Deal With Janssen Oncology
5M ago
8K
CHRS
Coherus Biosciences Updates ATM Equity Offering Program
PremiumCompany AnnouncementsCoherus Biosciences Updates ATM Equity Offering Program
5M ago
8K
CHRS
Coherus Oncology initiated with an Outperform at Oppenheimer ahead of readouts
Premium
The Fly
Coherus Oncology initiated with an Outperform at Oppenheimer ahead of readouts
6M ago
CHRS
Coherus Oncology initiated with an Outperform at Oppenheimer
Premium
The Fly
Coherus Oncology initiated with an Outperform at Oppenheimer
6M ago
CHRS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >